Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 08-2024 | 05-2024 | 02-2024 | 11-2023 | 08-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,230 | N/A | 19,096 | 3,464 | -10,754 |
| Depreciation Amortization | 1,993 | N/A | 5,940 | 3,934 | 2,168 |
| Income taxes - deferred | N/A | N/A | N/A | 36 | 76 |
| Accounts receivable | 6,075 | N/A | -2,711 | -1,212 | 2,386 |
| Accounts payable and accrued liabilities | 3,628 | N/A | -4,617 | -4,261 | -4,202 |
| Other Working Capital | 7,497 | N/A | -8,143 | -3,411 | -4,201 |
| Other Operating Activity | -3,576 | 0 | -18,024 | -5,591 | 6,198 |
| Operating Cash Flow | $-613 | $N/A | $-8,459 | $-7,041 | $-8,329 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,422 | N/A | -15,682 | -9,315 | -5,054 |
| Investing Cash Flow | $-3,422 | $N/A | $-15,682 | $-9,315 | $-5,054 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 31,824 | N/A | 3,104 | 69 | 2,281 |
| Debt Repayment | -233 | N/A | -482 | -250 | -26 |
| Common Stock Issued | 1 | N/A | 724 | 724 | 724 |
| Other Financing Activity | -30,499 | 0 | 4,777 | -57 | -45 |
| Financing Cash Flow | $1,093 | $N/A | $8,123 | $486 | $2,934 |
| Beginning Cash Position | 8,462 | N/A | 19,091 | 19,091 | 19,091 |
| End Cash Position | 5,520 | N/A | 3,073 | 3,221 | 8,642 |
| Net Cash Flow | $-2,942 | $N/A | $-16,018 | $-15,870 | $-10,449 |
| Free Cash Flow | |||||
| Operating Cash Flow | -613 | N/A | -8,459 | -7,041 | -8,329 |
| Capital Expenditure | -3,422 | N/A | -15,682 | -9,315 | -5,054 |
| Free Cash Flow | -4,035 | 0 | -24,141 | -16,356 | -13,383 |